NCT03649126

Brief Summary

The first objective is to explore factors that impede or facilitate implementation of SSR in pathology (and other disciplines) among the MDT members receiving SSRs. The second objective is to select, develop and evaluate (process and effect outcomes) implementation tools supporting optimal implementation of SSR in pathology. The third objective is to offer implementation tools to all pathology laboratories in the Netherlands and to share the SSR-kit for successful implementation with other medical disciplines

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

August 21, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 28, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

August 28, 2018

Status Verified

August 1, 2018

Enrollment Period

1.9 years

First QC Date

August 14, 2018

Last Update Submit

August 27, 2018

Conditions

Keywords

standardized structured reportingtreatment decisionsmultidisciplinary teampathologyimplementation tools

Outcome Measures

Primary Outcomes (2)

  • Barriers and facilitators in implementation of SSR in MDT - focus groups and self-developed questionnaire

    Barriers and facilitators in implementation of SSR among MDT members measured by focus groups and a self-developed questionnaire

    9 months

  • Effectiveness of implementation tools - frequencies of use of SSR templates in pathology in the Netherlands

    The improvement in use of SSR templates in the Netherlands (=effectiveness of implementation tools) measured by frequencies of use of SSR templates in pathology (=all laboratories in the Netherlands)

    6 months

Secondary Outcomes (3)

  • Determinants of barriers and facilitators in implementation of SSR - focus groups and a self-developed questionnaire

    1 month

  • Experiences with implementation tools - questionnaire

    6 months

  • Use of implementation tools - questionnaire

    6 months

Study Arms (6)

Dutch pathologists hospital I

Pathologists in hospital I using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer

Behavioral: Implementation tools

Dutch pathologists hospital II

Pathologists in hospital II using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer

Behavioral: Implementation tools

Dutch pathologists hospital III

Pathologists in hospital III using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer

Behavioral: Implementation tools

Dutch pathologists hospital IV

Pathologists in hospital IV using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer

Behavioral: Implementation tools

Dutch pathologists hospital V

Pathologists in hospital V using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer

Behavioral: Implementation tools

Dutch pathologists hospital VI

Pathologists in hospital VI using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer

Behavioral: Implementation tools

Interventions

Implementation tools developed by experts in order to increase the use of SSR in pathology

Dutch pathologists hospital IDutch pathologists hospital IIDutch pathologists hospital IIIDutch pathologists hospital IVDutch pathologists hospital VDutch pathologists hospital VI

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Dutch pathologists, MDT-members and residents, using SSR of urological, gynecological or gastro-intestinal cancers.

You may qualify if:

  • Pathologists of urological, gynecological or gastro-intestinal cancers
  • Other MDT-members of urological, gynecological or gastro-intestinal cancers (medical oncologists, radiologists, radiotherapists, urologists, gynecologists, intestinal surgeons, nuclear medicine physicians, nurse practitioners).
  • Dutch
  • Residents

You may not qualify if:

  • Retirees

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud University Nijmegen Medical Center

Nijmegen, Gelderland, 6525GA, Netherlands

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr.

Study Record Dates

First Submitted

August 14, 2018

First Posted

August 28, 2018

Study Start

August 21, 2018

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

August 28, 2018

Record last verified: 2018-08

Locations